Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$2.35.

  • Sanofi's EPS (Basic) rose 9999.41% to -$2.35 in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.35, marking a year-over-year increase of 9999.41%. This contributed to the annual value of $7.23 for FY2025, which is 5050.53% up from last year.
  • Latest data reveals that Sanofi reported EPS (Basic) of -$2.35 as of Q4 2025, which was up 9999.41% from $607431.0 recorded in Q3 2025.
  • Sanofi's EPS (Basic)'s 5-year high stood at $1.1 million during Q2 2025, with a 5-year trough of -$40090.1 in Q4 2024.
  • For the 5-year period, Sanofi's EPS (Basic) averaged around $317526.4, with its median value being $76763.0 (2025).
  • As far as peak fluctuations go, Sanofi's EPS (Basic) skyrocketed by 464023.45% in 2022, and later tumbled by 1143059835.21% in 2024.
  • Over the past 5 years, Sanofi's EPS (Basic) (Quarter) stood at $0.2 in 2021, then surged by 4640.23% to $9.59 in 2022, then crashed by 103.66% to -$0.35 in 2023, then plummeted by 11430598.35% to -$40090.1 in 2024, then soared by 99.99% to -$2.35 in 2025.
  • Its EPS (Basic) stands at -$2.35 for Q4 2025, versus $607431.0 for Q3 2025 and $1.1 million for Q2 2025.